Go to content
- {{#headlines}}
- {{title}} {{/headlines}}
Profile
| Academic position | Full Professor |
|---|---|
| Research fields | Pharmacy,Pharmacology,Bioorganic and Biological Chemistry |
| Keywords | Drug Development, Drug Design, Pharmaceutical Chemistry, Pharmacy, Drug Design and Optimization |
Current contact address
| Country | Egypt |
|---|---|
| City | Cairo |
| Institution | German University in Cairo - GUC |
| Institute | Faculty of Pharmacy and Biotechnology |
Host during sponsorship
| Prof. Dr. Jochen Lehmann | Pharmazeutisches Institut, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn |
|---|---|
| Prof. Dr. Peter Gmeiner | Department of Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen |
| Prof. Dr. Jochen Lehmann | Fakultät für Biowissenschaften, Friedrich-Schiller-Universität Jena, Jena |
| Prof. Dr. Rolf W. Hartmann | Lehrstuhl für Pharmazeutische und Medizinische Chemie, Universität des Saarlandes, Saarbrücken |
| Prof. Dr. Jochen Lehmann | Institut für Pharmazie - Lehrstuhl für Pharmazeutische / Medizinische Chemie, Friedrich-Schiller-Universität Jena, Jena |
| Start of initial sponsorship | 01/02/2000 |
Program(s)
| 1999 | Georg Forster Research Fellowship Programme |
|---|
Publications (partial selection)
| 2007 | Fadi M. Awallah, Franziska Müller, Jochen Lehmann, Ashraf H. Abadi: Synthesis of novel lactam derivatives and their evaluation as ligands for the dopamine receptors, leading to a D4-selective ligand. In: Bioorganic & Medicinal Chemistry, 2007, 5811-5818 |
|---|---|
| 2003 | Ashraf H. Abadi and Brun R.: Synthesis and Evaluation of Novel 7-Trifluoromethyl-4-(4-substituted anilino)quinolines as Antiparasitic and Antineoplastic Agents . In: Arzneimittel-Forschung/Drug Research , 2003, 655-663 |
| 2002 | Abadi AH, Lankow S, Hoefgen B, Decker M, Kassack MU, Lehmann J.: Dopamine/Serotonin Receptor Ligands, Part III [1Antagonist. In: Arch. Pharm. Pharm. Med. Chem. , 2002, 367-373 |
| 2001 | Ashraf H. Abadi, Stefan Laufer, Jochen Lehmann: Synthesis and Cyclooxygenase Inhibitory Properties of Novel (+) 2-(6-Methoxy-2-naphthyl)propanoic Acid (Naproxene) Derivatives. In: Arch. Pharm. Pharm. Med. Chem., 2001, 104-106 |
| 1999 | Ashraf H. Abadi, H.I. El-Subbagh, J. Lehmann: 2,4-disubstituted-thiazoles III. Synthesis and antitumor activity of ethyl 2-substituted-aminothiazole-4-carboxylate analogs. In: Arch. Pharm. Pharm. Med. Chem., 1999, 137-142 |